Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Therapeutic response decreased? 382 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 382 reports of Therapeutic response decreased have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.

382
Reports of Therapeutic response decreased with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
42
Deaths
37
Hospitalizations

How Dangerous Is Therapeutic response decreased From LENALIDOMIDE?

Of the 382 reports, 42 (11.0%) resulted in death, 37 (9.7%) required hospitalization, and 14 (3.7%) were considered life-threatening.

Is Therapeutic response decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 382 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Therapeutic response decreased?

DUPILUMAB (7,824) ETANERCEPT (3,460) ONABOTULINUMTOXINA (2,685) METHOTREXATE (2,668) INFLIXIMAB (1,991) RITUXIMAB (1,728) LEFLUNOMIDE (1,574) TOCILIZUMAB (1,512) HYDROXYCHLOROQUINE (1,485) ADALIMUMAB (1,357)

Which LENALIDOMIDE Alternatives Have Lower Therapeutic response decreased Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Therapeutic response decreased Reports All Drugs Causing Therapeutic response decreased LENALIDOMIDE Demographics